Cargando…

A Peptide-Based Nanocarrier for an Enhanced Delivery and Targeting of Flurbiprofen into the Brain for the Treatment of Alzheimer’s Disease: An In Vitro Study

Alzheimer’s disease (AD) is an age-related disease caused by abnormal accumulation of amyloid-β in the brain leading to progressive tissue degeneration. Flurbiprofen (FP), a drug used to mitigate the disease progression, has low efficacy due to its limited permeability across the blood–brain barrier...

Descripción completa

Detalles Bibliográficos
Autores principales:	Al-azzawi, Shafq, Masheta, Dhafir, Guildford, Anna, Phillips, Gary, Santin, Matteo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7466704/ https://www.ncbi.nlm.nih.gov/pubmed/32823499 http://dx.doi.org/10.3390/nano10081590

Ejemplares similares

Dendrimeric Poly(Epsilon-Lysine) Delivery Systems for the Enhanced Permeability of Flurbiprofen across the Blood-Brain Barrier in Alzheimer’s Disease
por: Al-azzawi, Shafq, et al.
Publicado: (2018)

Designing and Characterization of a Novel Delivery System for Improved Cellular Uptake by Brain Using Dendronised Apo-E-Derived Peptide
por: Al-azzawi, Shafq, et al.
Publicado: (2019)

Metal organic frameworks as a drug delivery system for flurbiprofen
por: AL Haydar, Muder, et al.
Publicado: (2017)

Lipid nanoparticles for transdermal delivery of flurbiprofen: formulation, in vitro, ex vivo and in vivo studies
por: Bhaskar, Kesavan, et al.
Publicado: (2009)

Topical Delivery of Flurbiprofen from Pluronic Lecithin Organogel
por: Pandey, M. S., et al.
Publicado: (2009)

Carboxybetaine-modified succinylated chitosan-based beads encourage pancreatic β-cells (Min-6) to form islet-like spheroids under in vitro conditions
por: Perugini, Valeria, et al.
Publicado: (2017)

Nanocarrier system: An emerging strategy for bioactive peptide delivery
por: Zhang, Xu, et al.
Publicado: (2022)

A multistep in vitro hemocompatibility testing protocol recapitulating the foreign body reaction to nanocarriers
por: Perugini, Valeria, et al.
Publicado: (2022)

Enhance transdermal delivery of flurbiprofen via microemulsions: Effects of different types of surfactants and cosurfactants
por: Idrees, MA., et al.
Publicado: (2011)

Nanoparticulate flurbiprofen reduces amyloid-β(42) generation in an in vitro blood–brain barrier model
por: Meister, Sabrina, et al.
Publicado: (2013)

Rational design of gold nanocarrier for the delivery of JAG-1 peptide
por: Matea, Cristian T, et al.
Publicado: (2015)

Cell-penetrating peptides and their analogues as novel nanocarriers for drug delivery
por: Jafari, Samira, et al.
Publicado: (2015)

Peptide-Functionalized Dendrimer Nanocarriers for Targeted Microdystrophin Gene Delivery
por: Hersh, Jessica, et al.
Publicado: (2021)

Hyperbranched poly(ϵ-lysine) substrate presenting the laminin sequence YIGSR induces the formation of spheroids in adult bone marrow stem cells
por: Perugini, Valeria, et al.
Publicado: (2017)

Flurbiprofen-Loaded Solid SNEDDS Preconcentrate for the Enhanced Solubility, In-Vitro Dissolution and Bioavailability in Rats
por: Kim, Rae Man, et al.
Publicado: (2018)

Population pharmacokinetic modeling of flurbiprofen, the active metabolite of flurbiprofen axetil, in Chinese patients with postoperative pain
por: Zhang, Jingru, et al.
Publicado: (2018)

Enhanced brain delivery of lamotrigine with Pluronic(®) P123-based nanocarrier
por: Liu, Jian-Sheng, et al.
Publicado: (2014)

Flurbiprofen loaded ethosomes - transdermal delivery of anti-inflammatory effect in rat model
por: Paliwal, Sarvesh, et al.
Publicado: (2019)

Optimization of Chitosan-Decorated Solid Lipid Nanoparticles for Improved Flurbiprofen Transdermal Delivery
por: Burki, Firdous Ahmad, et al.
Publicado: (2023)

Population Pharmacokinetic Modeling of Flurbiprofen, the Active Metabolite of Flurbiprofen Axetil, in Chinese Patients with Postoperative Pain [Corrigendum]
Publicado: (2020)

Development and In Vitro Characterization of Antibiotic-Loaded Nanocarriers for Dental Delivery
por: Ghazwani, Mohammed, et al.
Publicado: (2023)

Design of Targeted Flurbiprofen Biomimetic Nanoparticles for Management of Arthritis: In Vitro and In Vivo Appraisal
por: Mohamed, Hagar I., et al.
Publicado: (2022)

Population Pharmacokinetic Modeling Of Flurbiprofen, The Active Metabolite Of Flurbiprofen Axetil, In Chinese Patients With Postoperative Pain [Expression Of Concern]
Publicado: (2019)

The Comparison of Plasma and Cerebrospinal Fluid R(−)- and S(+)-Flurbiprofen Concentration After Intravenous Injection of Flurbiprofen Axetil in Human Subjects
por: Yao, Han, et al.
Publicado: (2021)

Phage display: development of nanocarriers for targeted drug delivery to the brain
por: Bakhshinejad, Babak, et al.
Publicado: (2015)

Nanocarrier-Based Drug Delivery to Brain: Interventions of Surface Modification
por: Sharma, Surbhi, et al.
Publicado: (2023)

Colloidal nanocarriers for the enhanced cutaneous delivery of naftifine: characterization studies and in vitro and in vivo evaluations
por: Erdal, M Sedef, et al.
Publicado: (2016)

Formulation optimization, in vitro and in vivo evaluation of niosomal nanocarriers for enhanced topical delivery of cetirizine
por: Aldawsari, Mohammed F., et al.
Publicado: (2023)

Bacterial magnetosomes-based nanocarriers for co-delivery of cancer therapeutics in vitro
por: Long, Rui-Min, et al.
Publicado: (2018)

Gel-Based Nanocarrier for Intravesical Chemotherapy Delivery: In Vitro and In Vivo Study
por: Chen, Ting-Yu, et al.
Publicado: (2020)

Nanocarriers for Nitric Oxide Delivery
por: Saraiva, Juliana, et al.
Publicado: (2011)

Polymeric Nanocarriers for the Delivery of Antimalarials
por: Mhlwatika, Zandile, et al.
Publicado: (2018)

Nanocarriers for Delivery of Oligonucleotides to the CNS
por: Male, David, et al.
Publicado: (2022)

DDEL-04. ENGINEERED NANOCARRIERS TO ENHANCE DRUG DELIVERY ACROSS THE BLOOD-BRAIN BARRIER
por: Straehla, Joelle P, et al.
Publicado: (2020)

Implications of biomimetic nanocarriers in targeted drug delivery
por: Al-Hetty, Hussein Riyadh Abdul Kareem, et al.
Publicado: (2023)

Inhibition of Endocannabinoid Metabolism by the Metabolites of Ibuprofen and Flurbiprofen
por: Karlsson, Jessica, et al.
Publicado: (2014)

Surface-Modified Nanocarriers for Nose-to-Brain Delivery: From Bioadhesion to Targeting
por: Sonvico, Fabio, et al.
Publicado: (2018)

Chiral 4-O-acylterpineol as transdermal permeation enhancers: insights of the enhancement mechanisms of a transdermal enantioselective delivery system for flurbiprofen
por: Chu, Tianzhe, et al.
Publicado: (2020)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
por: Jalili, Cyrus, et al.
Publicado: (2023)

An In-vitro Investigation of Swelling Controlled Delivery of Insulin from Egg Albumin Nanocarriers
por: Mahobia, Swati, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_28st0sh5e5566kvhrpc331acrq